Insight into the 2024 Chinese Orthopedic Surgical Robot Market

2025-02-10

The orthopedic surgical robot consists of three parts: control system, vision system, and robotic arm. The control system adjusts the surgical plan, the vision system is responsible for real-time data transmission and displays the operation plan, and the roboThe workflow is assisted by three steps: preoperative anatomical planning, robotic arm registration and osteotomy, and navigation positioning monitoring to complete the surgery.

Orthopedic surgical robots are mainly used in joint replacement surgery, spinal surgery, and orthopedic trauma surgery. Among these three types of surgeries, robot assisted joint replacement surgery is the most widely used and complex one.Since 2022, the number of registered orthopedic surgical robots in China has surged. In September 2024, the first sports medicine surgical robot in China was approved for market by the National Medical Products Administration. As of now, the proportion of domestic registrations has exceeded 90%.By 2024, the localization rate of domestic orthopedic surgical robots in the market exceeded 70%. In the future, with the layout of new products in hospitals, the market share of domestic orthopedic surgical robots will further increase.

This report aims to comprehensively analyze the scale, brand structure, regional differentiation performance, and other aspects of the domestic orthopedic surgical robot market in 2024, and gain insights into market trends.

Overall market

Market size

In 2024, the sales of orthopedic surgical robots in China reached nearly 100 units (of which 74 units can be found in public data, and some data is non-public information), and the market size steadily grew; The number of domestic orthopedic surgical robot surgeries has increased by over 70% year-on-year, with TINAVI orthopedic surgical robot surgeries exceeding 39000 cases, accounting for 74%.

It is particularly noteworthy that the clinical application of orthopedic surgical robots has shown an accelerated trend in recent years. Taking the data disclosed in TINAVI’s annual report as an example, by the end of 2022, the cumulative number of orthopedic surgery robots had exceeded 30,000 cases, and by the end of 2023 it had exceeded 60,000 cases, while the latest company performance forecast data shows that by the end of 2024, its surgical application has exceeded 100,000 cases.

| 2、Market Pattern

（1）Localization rate

In 2024, the domestic market share of orthopedic surgical robots in China exceeded 70%, increasing by approximately 6 percentage points year-on-year.With the rapid growth of domestic registration certificates in the past three years, by the end of 2024, the domestic share has exceeded 90%, and the localization rate of orthopedic surgical robots in the market is expected to further increase.

（2）Brand pattern

In 2024, in the domestic orthopedic surgery robot market, TINAVI’s sales volume and sales market share ranked first. According to statistics, TINAVI orthopedic surgery robots have sold 35 units (including technical service installation); TuodaoMedical and Medtronic ranked second and third, and the market concentration (CR4) of the top four brands was 77.33%, down 7.4 percentage points year-on-year.

From the model point of view, TINAVI’s TiRobot ForcePro Superior is the most popular product in the market at present.

From the perspective of application scope, orthopedic surgical robots suitable for spinal surgery were the most widely used, with sales accounting for about half of the overall market, and their proportion has significantly increased compared to the same period last year.

①Spinal surgery robot

]In the domestic spine surgery robot market, TINAVI, TuodaoMedical, Medtronic and Zoezen occupied the top four positions in terms of market share. CR4 was 94.15%, down 3.9 percentage points year-on-year.

②Orthopedic joint surgery robot

In the domestic orthopedic surgery robot market, TINAVI and Stryker market share ranked the top two, Zimmer Biomet and Yuanhua Tech ranked third and fourth. Of these, CR4 was close to 80%, down nearly 19 percentage points year-on-year.

③Traumatic orthopedic surgery robot

In the domestic trauma orthopedic surgical robot market, TINAVI still dominated and its market share has increased by nearly 10 percentage points year-on-year, with the emerging brand Rossum Robot entering the market.

District market

1.Spinal surgery robot

In 2024, the proportion of procurement of domestic spinal surgery robots in the eastern and western regions has increased significantly, especially in the eastern region, which has increased by nearly 15 percentage points year-on-year.

From the perspective of brand market share, TINAVI ranked first in the western and northeast regions of China; Tuodao Medical and Medtronic were more prominent in the eastern and central regions respectively. Santan Medical was more active in the Northeast.

2.Orthopedic joint surgery robot

In 2024, the proportion of domestic orthopedic surgery robots purchased in the eastern region increased significantly, increasing by more than 20 percentage points year-on-year.

]In terms of brand market share, TINAVI ranked first in the eastern, western and central regions of China, with the most prominent advantage in the central region; Micro Port was the most active in Northeast China. Stryker and HRB performed better in the eastern region and the western region respectively.

3..Traumatic orthopedic surgery robot

In 2024, the proportion of domestic orthopaedic trauma surgery robots in the eastern and western regions increased significantly, especially in the western region, which increased by nearly 15 percentage points year-on-year.

Procurement at the hospital end

1、Overall situation

In 2024, domestic orthopaedic surgical robots were still mainly distributed in third-level hospitals, and the proportion of orthopaedic surgical robots purchased by second-level and below hospitals has increased significantly.Although orthopedic surgery robots will not sink to grass-roots hospitals on a large scale, it has become an inevitable trend of market development to penetrate from advantageous hospitals in first and second-tier cities to regional medical institutions.

（1）Spinal surgery robot

From the perspective of the market pattern of spinal surgery robots in domestic hospitals of all levels, the advantages of Medtronic and TINAVI were more obvious in tertiary hospitals, and the performance of TINAVI, Tuodao Medical and Perlove Medical was more prominent in secondary and below grade hospitals.

（2）Orthopedic joint surgery robot

From the perspective of the market pattern of orthopedic joint surgery robots in domestic hospitals of all levels, TINAVI, Zimmer Biomet, Yuanhua Tech and Jianjia Robot had more prominent advantages in tertiary hospitals, and Stryker had a more outstanding performance in secondary and below grade hospitals.

2、 County-level hospitals

In 2024, the procurement proportion of orthopedic surgical robots in county-level hospitals in China remaind at around 13%. The orthopedic surgical robots purchased by county-level hospitals were mainly domestic brands such as TINAVI, Yuanhua Tech, Tuodao Medical, Lancet Robotics, and Santan Medical Technology.

China is encouraging China end uses for more domestic products in latest years. Thus, more and more overseas manufacturers are planning localization in China. BradyKnows localization team has extensive experiences in facility establishment, audit, supplier evaluation, manufacturing, registration, and marketing in China. Pls feel free to let us know any questions on China entry via info@bradyknowsmedical.com

Source：Yizhuanshusheng
Translated & edited： Bradyknown